Paul Douglas Ossman, MD, MPH | |
Unc Hospitals Chapel Hill Campus 101 Manning Dr, Campus Box 7085, Chapel Hill, NC 27599-7085 | |
(984) 974-1931 | |
(984) 974-2216 |
Full Name | Paul Douglas Ossman |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 18 Years |
Location | Unc Hospitals Chapel Hill Campus 101 Manning Dr, Chapel Hill, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104041672 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 2009-00442 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of North Carolina Hospital | Chapel hill, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's Center for Translational Medicine think could be prevented with new medicines.
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
About 50 % of women with uterine fibroids-non-cancerous muscle tumors that grow in the uterus-experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended when these symptoms are severe enough to prompt a woman to seek treatment.
› Verified 9 days ago
Entity Name | University Of North Carolina At Chapel Hill |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's Center for Translational Medicine think could be prevented with new medicines.
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
About 50 % of women with uterine fibroids-non-cancerous muscle tumors that grow in the uterus-experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended when these symptoms are severe enough to prompt a woman to seek treatment.
› Verified 9 days ago
Entity Name | Chatham Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689967457 PECOS PAC ID: 4284807868 Enrollment ID: O20111026000545 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's Center for Translational Medicine think could be prevented with new medicines.
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
About 50 % of women with uterine fibroids-non-cancerous muscle tumors that grow in the uterus-experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended when these symptoms are severe enough to prompt a woman to seek treatment.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Paul Douglas Ossman, MD, MPH Unc Hospitals Chapel Hill Campus 101 Manning Dr, Campus Box 7085, Chapel Hill, NC 27599-7085 Ph: (984) 974-1931 | Paul Douglas Ossman, MD, MPH Unc Hospitals Chapel Hill Campus 101 Manning Dr, Campus Box 7085, Chapel Hill, NC 27599-7085 Ph: (984) 974-1931 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's Center for Translational Medicine think could be prevented with new medicines.
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
About 50 % of women with uterine fibroids-non-cancerous muscle tumors that grow in the uterus-experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended when these symptoms are severe enough to prompt a woman to seek treatment.
› Verified 9 days ago
Ria Dancel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Cb 7085, Chapel Hill, NC 27514 Phone: 984-974-1931 | |
Dr. William Allen Kwan Jr., M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Drive Cb 7085, Chapel Hill, NC 27599 Phone: 984-974-1931 Fax: 984-974-2216 | |
Dr. Robert William Lampman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1931 Fax: 984-974-2216 | |
Dr. Amir Homayoun Barzin, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 590 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-0210 | |
Shannon R Morris, M.D., PH.D Hospitalist Medicare: Not Enrolled in Medicare Practice Location: Physicians Office Building 3rd Floor Cb 7305, 170 Manning Drive, Chapel Hill, NC 27599 Phone: 919-483-7282 | |
Dr. Leonardo Marucci, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Campus Box 7085, Chapel Hill, NC 27599 Phone: 984-974-1931 Fax: 984-974-2216 |